(Q48662099)

English

Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure.

scientific article published on 3 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

0 references

author name string

Horng H Chen

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

John A Schirger

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

Alessandro Cataliotti

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

John C Burnett

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

publication date

3 February 2006

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

European Journal of Heart Failure

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

8

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

681-686

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.005

21 January 2018

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.005

21 January 2018

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.005

21 January 2018

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.005

21 January 2018

Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.12.005

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.12.005

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16459135

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48662099&oldid=1320036330"